PaccMann-MCA

Prediction of AntiCancer Compound sensitivity with Multi-modal Attention-based Neural Networks

Model Architecture

The PaccMann-MCA model is composed of a network propagation layer, an attention-based gene expression encoder, a SMILES embedding layer and a SMILES encoder. The gene expression encoder generates attention weights to encode the cell-line gene expression. The model uses multiscale convolutional attention (MCA) mechanism for the SMILES encoders. The MCA mechanism enables to incorporate both positional information and long-range dependencies using a combination of convolutional layers and contextual attention mechanisms. Finally the encoded drug and cell-line features are concatenated and inputted to fully connected dense layers to predict the drug response.

Feature Representation

  • Cancer features:

    • Gene Expression: RMA-normalized

  • Drug features:

    • SMILES

    • Morgan fingerprints

URLs

References

1. M. Manica, et. al. “Toward Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-Based Convolutional Encoders”, Mol. Pharmaceutics, 2019